Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07207681 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

Name: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors — clinical trial record (NCT07207681)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorThe First Hospital of Jilin University

Started2025-10-15

View on ClinicalTrials.gov ↗

The First Hospital of Jilin University

86 trials monitored

See 2 trials at risk

This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.

Trial Details

NCT Number	NCT07207681
Lead Sponsor	The First Hospital of Jilin University
Conditions	Advanced Solid Tumors
Enrollment	30 participants
Start Date	2025-10-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-10-06